{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:30:42Z","timestamp":1781933442125,"version":"3.54.5"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":81,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.smim.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,24]],"date-time":"2018-06-24T11:16:18Z","timestamp":1529838978000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Correlates of immune exacerbations in leprosy"],"prefix":"10.1016","volume":"39","author":[{"given":"Annemieke","family":"Geluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.47276\/lr.85.1.2","article-title":"Role of contact tracing and prevention strategies in the interruption of leprosy transmission","volume":"85","author":"Smith","year":"2014","journal-title":"Lepr. Rev."},{"issue":"35","key":"10.1016\/j.smim.2018.06.003_bib0010","first-page":"405","article-title":"Global leprosy update, 2015: time for action, accountability and inclusion","volume":"91","year":"2015","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"35","key":"10.1016\/j.smim.2018.06.003_bib0015","first-page":"15","article-title":"Global leprosy update 2015: time for action, accountability and inclusion","volume":"91","author":"WHO","year":"2016","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003658","article-title":"The missing millions: a threat to the elimination of leprosy","volume":"9","author":"Smith","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1471-2164-15-270","article-title":"Mycobacterium leprae genomes from a British medieval leprosy hospital: towards understanding an ancient epidemic","volume":"15","author":"Mendum","year":"2014","journal-title":"BMC Genom."},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0030","doi-asserted-by":"crossref","first-page":"e5669","DOI":"10.1371\/journal.pone.0005669","article-title":"Schug MD: ancient skeletal evidence for leprosy in India (2000 B.C.)","volume":"4","author":"Robbins","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2018.06.003_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.inhe.2011.09.006","article-title":"Nerve damage in leprosy: a continuing challenge for scientists, clinicians and service providers","volume":"4","author":"Lockwood","year":"2012","journal-title":"Int. Health"},{"issue":"6975","key":"10.1016\/j.smim.2018.06.003_bib0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature02326","article-title":"Susceptibility to leprosy is associated with PARK2 and PACRG","volume":"427","author":"Mira","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng.3212","article-title":"Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy","volume":"47","author":"Liu","year":"2015","journal-title":"Nat. Genet"},{"issue":"27","key":"10.1016\/j.smim.2018.06.003_bib0050","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","article-title":"Genomewide association study of leprosy","volume":"361","author":"Zhang","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.smim.2018.06.003_bib0055","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1371\/journal.pntd.0002338","article-title":"CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 t cells in human leprosy","volume":"7","author":"Saini","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.smim.2018.06.003_bib0060","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/IAI.61.8.3482-3489.1993","article-title":"Cytokine production at the site of disease in human tuberculosis","volume":"61","author":"Barnes","year":"1993","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1489\/1544-581X(2004)072<0166:COLAFC>2.0.CO;2","article-title":"Classification of leprosy: a full color spectrum, or black and white?","volume":"72","author":"Scollard","year":"2004","journal-title":"Int. J. Lepr. Mycobact. Dis."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0070","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int. J. Lepr. Mycobact. Dis."},{"issue":"5639","key":"10.1016\/j.smim.2018.06.003_bib0075","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.1087785","article-title":"Use of genetic profiling in leprosy to discriminate clinical forms of the disease","volume":"301","author":"Bleharski","year":"2003","journal-title":"Science (New York, N. Y.)"},{"issue":"15","key":"10.1016\/j.smim.2018.06.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88843","article-title":"Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy","volume":"1","author":"Inkeles","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0085","doi-asserted-by":"crossref","first-page":"e2773","DOI":"10.1371\/journal.pntd.0002773","article-title":"T-cell regulation in lepromatous leprosy","volume":"8","author":"Bobosha","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0095","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1073\/pnas.85.4.1213","article-title":"Learning from lesions: patterns of tissue inflammation in leprosy","volume":"85","author":"Modlin","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9416","key":"10.1016\/j.smim.2018.06.003_bib0100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"363","author":"Britton","year":"2004","journal-title":"Lancet (Lond., Engl.)"},{"issue":"12","key":"10.1016\/j.smim.2018.06.003_bib0105","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1371\/journal.pntd.0001327","article-title":"Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort","volume":"5","author":"Lockwood","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4269\/ajtmh.13-0221","article-title":"Risk factors for leprosy reactions in three endemic countries","volume":"92","author":"Scollard","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.47276\/lr.79.4.372","article-title":"Leprosy type 1 (reversal) reactions and their management","volume":"79","author":"Walker","year":"2008","journal-title":"Lepr. Rev."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0120","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1371\/journal.pntd.0002089","article-title":"Diagnosis and treatment of leprosy reactions in integrated services \u2013 the patients\u2019 perspective in Nepal","volume":"7","author":"Raffe","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fimmu.2017.00233","article-title":"A systematic review of immunological studies of erythema nodosum leprosum","volume":"8","author":"Polycarpou","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","article-title":"Cytokine patterns of immunologically mediated tissue damage","volume":"149","author":"Yamamura","year":"1992","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1086\/509923","article-title":"Alcais a: age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy","volume":"44","author":"Ranque","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"1-2","key":"10.1016\/j.smim.2018.06.003_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00335-010-9287-1","article-title":"Leprosy as a genetic disease","volume":"22","author":"Alter","year":"2011","journal-title":"Mamm. Genome"},{"issue":"10","key":"10.1016\/j.smim.2018.06.003_bib0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/652007","article-title":"A major gene controls leprosy susceptibility in a hyperendemic isolated population from north of Brazil","volume":"201","author":"Lazaro","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0039.1984.tb00393.x","article-title":"Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population","volume":"24","author":"Ottenhoff","year":"1984","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/MMBR.00025-10","article-title":"Leprosy and the human genome","volume":"74","author":"Misch","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006637","article-title":"A genome wide association study identifies a lncRna as risk factor for pathological inflammatory responses in leprosy","volume":"13","author":"Fava","year":"2017","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0165","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/141.6.693","article-title":"HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker","volume":"141","author":"van","year":"1980","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajhg.2018.03.006","article-title":"Missense variants in HIF1A and LACC1 contribute to leprosy risk in Han Chinese","volume":"102","author":"Wang","year":"2018","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0175","first-page":"559","article-title":"Epidemiologic characteristics of leprosy reactions","volume":"62","author":"Scollard","year":"1994","journal-title":"Int. J. Lepr. Mycobact. Dis."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0180","first-page":"316","article-title":"Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum","volume":"66","author":"Rea","year":"1998","journal-title":"Int. J. Lepr. Mycobact. Dis."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0185","first-page":"521","article-title":"HLA class II immune response and suppression genes in leprosy","volume":"55","author":"Ottenhoff","year":"1987","journal-title":"Int. J. Lepr. Mycobact. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.smim.2018.06.003_bib0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S0074-02762012000900020","article-title":"Genetics of leprosy reactions: an overview","volume":"107","author":"Fava","year":"2012","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nm864","article-title":"Activation and regulation of Toll-like receptors 2 and 1 in human leprosy","volume":"9","author":"Krutzik","year":"2003","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/524688","article-title":"Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy","volume":"197","author":"Bochud","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0205","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1371\/journal.pntd.0000231","article-title":"Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction","volume":"2","author":"Misch","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0210","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4049\/jimmunol.1600042","article-title":"DNA sensing via TLR-9 constitutes a major innate immunity pathway activated during erythema nodosum leprosum","volume":"197","author":"Dias","year":"2016","journal-title":"J. Immunol. (Baltim., Md : 1950)"},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2012.10891.x","article-title":"The effect of systemic corticosteroid therapy on the expression of toll-like receptor 2 and toll-like receptor 4 in the cutaneous lesions of leprosy type 1 reactions","volume":"167","author":"Walker","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.smim.2018.06.003_bib0220","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/infdis\/jis208","article-title":"Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction","volume":"205","author":"Sousa","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.smim.2018.06.003_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005754","article-title":"Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosy","volume":"11","author":"Sales-Marques","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fimmu.2017.00155","article-title":"Age-dependent association of TNFSF15\/TNFSF8 variants and leprosy type 1 reaction","volume":"8","author":"Fava","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2018.06.003_bib0235","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/infdis\/jir516","article-title":"Genetic variations and interactions in anti-inflammatory cytokine pathway genes in the outcome of leprosy: a study conducted on a MassARRAY platform","volume":"204","author":"Aggarwal","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.smim.2018.06.003_bib0240","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.gene.6364122","article-title":"Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy","volume":"5","author":"Moraes","year":"2004","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CVI.00033-16","article-title":"Field-friendly test for monitoring multiple immune response markers during onset and treatment of exacerbated immunity in leprosy","volume":"23","author":"Corstjens","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"issue":"10","key":"10.1016\/j.smim.2018.06.003_bib0250","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.4049\/jimmunol.166.10.5883","article-title":"Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy","volume":"166","author":"Spierings","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archderm.1985.01660020074021","article-title":"tissue and blood t-lymphocyte subpopulations in erythema nodosum leprosum","volume":"121","author":"Modlin","year":"1985","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0260","first-page":"17","article-title":"In situ characterization of T lymphocyte subsets in the reactional states of leprosy","volume":"53","author":"Modlin","year":"1983","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0265","first-page":"103","article-title":"Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states","volume":"84","author":"Sarno","year":"1991","journal-title":"Clin. Exp. Immunol."},{"issue":"5029","key":"10.1016\/j.smim.2018.06.003_bib0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.1925582","article-title":"Defining protective responses to pathogens: cytokine profiles in leprosy lesions","volume":"254","author":"Yamamura","year":"1991","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2133.2001.03970.x","article-title":"Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient","volume":"144","author":"Moraes","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0280","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03485.x","article-title":"Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions","volume":"150","author":"Iyer","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0285","first-page":"279","article-title":"Use of a whole blood assay to monitor the immune response to mycobacterial antigens in leprosy patients: a predictor for type 1 reaction onset?","volume":"69","author":"Weir","year":"1998","journal-title":"Lepr. Rev."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0295","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/CVI.00042-11","article-title":"Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions","volume":"18","author":"Scollard","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0300","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12879-015-1128-0","article-title":"Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal","volume":"15","author":"Khadge","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2334-9-75","article-title":"Potential plasma markers of type 1 and type 2 leprosy reactions: a preliminary report","volume":"9","author":"Stefani","year":"2009","journal-title":"BMC Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.smim.2018.06.003_bib0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2013.10.008","article-title":"Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy","volume":"156","author":"Chaitanya","year":"2013","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0315","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10875-012-9747-3","article-title":"Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy","volume":"32","author":"Chaitanya","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0320","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10875-013-9979-x","article-title":"Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions","volume":"34","author":"Geluk","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.smim.2018.06.003_bib0325","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2018.00604","article-title":"Emerging concepts of adaptive immunity in leprosy","volume":"9","author":"Sadhu","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0330","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trsl.2009.08.006","article-title":"Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis","volume":"154","author":"Simonian","year":"2009","journal-title":"Trans.Res."},{"issue":"13","key":"10.1016\/j.smim.2018.06.003_bib0335","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.smim.2018.06.003_bib0340","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.4049\/jimmunol.150.12.5501","article-title":"Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of t cell responses in leprosy","volume":"150","author":"Sieling","year":"1993","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2018.06.003_bib0345","doi-asserted-by":"crossref","first-page":"e3149","DOI":"10.1371\/journal.pntd.0003149","article-title":"IL-10 and NOS2 modulate antigen-specific reactivity and nerve infiltration by T cells in experimental leprosy","volume":"8","author":"Hagge","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0350","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4269\/ajtmh.15-0673","article-title":"Development of type 2, but not type 1, leprosy reactions is associated with a severe reduction of circulating and In situ regulatory T-Cells","volume":"94","author":"Vieira","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.smim.2018.06.003_bib0355","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/infdis\/jix267","article-title":"Elevated pentraxin-3 concentrations in patients with leprosy: potential biomarker of erythema nodosum leprosum","volume":"216","author":"Mendes","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0360","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cei.12767","article-title":"Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy","volume":"184","author":"Bahia El Idrissi","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0365","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1038\/s41598-017-07803-7","article-title":"Field-friendly serological tests for determination of M. leprae-specific antibodies","volume":"7","author":"van Hooij","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0370","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/0037-8682-0440-2015","article-title":"Number of leprosy reactions during treatment: clinical correlations and laboratory diagnosis","volume":"49","author":"Antunes","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/trstmh\/trx026","article-title":"Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis","volume":"111","author":"Serrano-Coll","year":"2017","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"8768","key":"10.1016\/j.smim.2018.06.003_bib0380","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0140-6736(91)91232-J","article-title":"Risk factors for type-1 reactions in borderline leprosy patients","volume":"338","author":"Roche","year":"1991","journal-title":"Lancet (Lond., Engl.)"},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0385","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1371\/journal.pntd.0000212","article-title":"Early diagnosis of neuropathy in leprosy-comparing diagnostic tests in a large prospective study (the INFIR cohort study)","volume":"2","author":"van Brakel","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2377-12-159","article-title":"Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols","volume":"12","author":"Wagenaar","year":"2012","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.smim.2018.06.003_bib0395","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/thoraxjnl-2015-207999","article-title":"Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB","volume":"71","author":"Chegou","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.smim.2018.06.003_bib0400","doi-asserted-by":"crossref","first-page":"34260","DOI":"10.1038\/srep34260","article-title":"Quantitative lateral flow strip assays as user-friendly tools to detect biomarker profiles for leprosy","volume":"6","author":"van Hooij","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0405","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CVI.00033-16","article-title":"Field-friendly test for monitoring multiple immune response markers during onset and treatment of exacerbated immunity in leprosy","volume":"23","author":"Corstjens","year":"2016","journal-title":"Clin. Vaccine Immunol. : CVI"},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0410","doi-asserted-by":"crossref","first-page":"86","DOI":"10.15252\/emmm.201505790","article-title":"Concise gene signature for point-of-care classification of tuberculosis","volume":"8","author":"Maertzdorf","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0415","doi-asserted-by":"crossref","first-page":"O230","DOI":"10.1111\/1469-0691.12383","article-title":"Differential gene expression of activating Fcgamma receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity","volume":"20","author":"Sutherland","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"10.1016\/j.smim.2018.06.003_bib0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001538","article-title":"Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study","volume":"10","author":"Kaforou","year":"2013","journal-title":"PLoS Med."},{"issue":"10035","key":"10.1016\/j.smim.2018.06.003_bib0425","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/S0140-6736(16)00165-3","article-title":"Predicting active tuberculosis progression by RNA analysis","volume":"387","author":"Levin","year":"2016","journal-title":"Lancet (Lond., Engl.)"},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0430","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ebiom.2014.12.001","article-title":"Biomarkers can identify pulmonary tuberculosis in HIV-infected drug users months prior to clinical diagnosis","volume":"2","author":"Sloot","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.smim.2018.06.003_bib0435","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","author":"Zak","year":"2016","journal-title":"Lancet (Lond., Engl.)"},{"issue":"7","key":"10.1016\/j.smim.2018.06.003_bib0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003624","article-title":"Gene set signature of reversal reaction type I in leprosy patients","volume":"9","author":"Orlova","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.smim.2018.06.003_bib0445","article-title":"Transcriptional changes that characterize the immune reactions of leprosy","author":"Dupnik","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"6126","key":"10.1016\/j.smim.2018.06.003_bib0450","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.1233665","article-title":"Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses","volume":"339","author":"Teles","year":"2013","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0455","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006321","article-title":"Complement C1q expression in erythema nodosum leprosum","volume":"12","author":"Negera","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1-2","key":"10.1016\/j.smim.2018.06.003_bib0465","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2017.12.025","article-title":"An integrated View of immunometabolism","volume":"172","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.smim.2018.06.003_bib0470","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.redox.2018.04.011","article-title":"Integrative metabolomics and transcriptomics signatures of clinical tolerance to plasmodium vivax reveal activation of innate cell immunity and T cell signaling","volume":"17","author":"Gardinassi","year":"2018","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.smim.2018.06.003_bib0475","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1021\/acs.jproteome.7b00173","article-title":"Serial metabolome changes in a prospective cohort of subjects with influenza viral infection and comparison with dengue fever","volume":"16","author":"Cui","year":"2017","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.smim.2018.06.003_bib0480","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI28996","article-title":"Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following listeria monocytogenes infection","volume":"116","author":"Popov","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"403","key":"10.1016\/j.smim.2018.06.003_bib0485","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2717","article-title":"Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI)","volume":"9","author":"Molins","year":"2017","journal-title":"Science Translational Med."},{"key":"10.1016\/j.smim.2018.06.003_bib0490","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-14-53","article-title":"A metabolic biosignature of early response to anti-tuberculosis treatment","volume":"14","author":"Mahapatra","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004449","article-title":"Metabolomics-based discovery of small molecule biomarkers in serum associated with dengue virus infections and disease outcomes","volume":"10","author":"Voge","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0500","first-page":"431","article-title":"Type 1 reaction in patients with leprosy corresponds to a decrease in proresolving lipid mediators and an increase in proinflammatory lipid mediators","volume":"215","author":"Silva","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.smim.2018.06.003_bib0505","doi-asserted-by":"crossref","first-page":"e1303","DOI":"10.1371\/journal.pntd.0001303","article-title":"Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis","volume":"5","author":"Al-Mubarak","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0510","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijid.2016.02.012","article-title":"exploratory urinary metabolomics of type 1 leprosy reactions","volume":"45","author":"Mayboroda","year":"2016","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.smim.2018.06.003_bib0515","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/505222","article-title":"Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases","volume":"43","author":"Scollard","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.02.017","article-title":"Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh","author":"Richardus","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2018.06.003_bib0525","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3389\/fimmu.2018.00629","article-title":"BCG and adverse events in the context of leprosy","volume":"9","author":"Richardus","year":"2018","journal-title":"Front. Immunol."},{"issue":"43","key":"10.1016\/j.smim.2018.06.003_bib0530","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0540","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13063-018-2623-6","article-title":"Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial","volume":"19","author":"Dos Santos","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.smim.2018.06.003_bib0545","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41541-018-0050-z","article-title":"LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection","volume":"3","author":"Duthie","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0550","doi-asserted-by":"crossref","first-page":"169","DOI":"10.47276\/lr.81.3.169","article-title":"Leprosy and HIV, where are we at?","volume":"81","author":"Lockwood","year":"2010","journal-title":"Lepr. Rev."},{"issue":"3","key":"10.1016\/j.smim.2018.06.003_bib0555","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/653839","article-title":"Leprosy and HIV coinfection: a clinical, pathological, immunological, and therapeutic study of a cohort from a Brazilian referral center for infectious diseases","volume":"202","author":"Talhari","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0560","doi-asserted-by":"crossref","first-page":"59","DOI":"10.47276\/lr.81.1.59","article-title":"Leprosy presenting as immune reconstitution inflammatory syndrome: proposed definitions and classification","volume":"81","author":"Deps","year":"2010","journal-title":"Lepr. Rev."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0565","doi-asserted-by":"crossref","first-page":"85","DOI":"10.47276\/lr.80.1.85","article-title":"Borderline tuberculoid leprosy with upgrading type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome","volume":"80","author":"Kar","year":"2009","journal-title":"Lepr. Rev."},{"issue":"6","key":"10.1016\/j.smim.2018.06.003_bib0570","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/eri.11.44","article-title":"Leprosy and HIV coinfection: a critical approach","volume":"9","author":"Massone","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"12","key":"10.1016\/j.smim.2018.06.003_bib0575","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/JCM.01425-06","article-title":"Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome","volume":"44","author":"Trindade","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0580","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12879-017-2406-9","article-title":"severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory t-cells?","volume":"17","author":"Vieira","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0585","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/698513","article-title":"Human immunodeficiency virus and leprosy coinfection: challenges in resource-limited setups","volume":"2012","author":"Kwobah","year":"2012","journal-title":"Case Rep. Med."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0590","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.det.2010.08.016","article-title":"Human immunodeficiency virus and leprosy: an update","volume":"29","author":"Lockwood","year":"2011","journal-title":"Dermatol. Clin."},{"issue":"10","key":"10.1016\/j.smim.2018.06.003_bib0595","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.trstmh.2008.06.003","article-title":"Leprosy occurring as immune reconstitution syndrome","volume":"102","author":"Deps","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"10","key":"10.1016\/j.smim.2018.06.003_bib0600","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.trstmh.2008.06.003","article-title":"Leprosy occurring as immune reconstitution syndrome","volume":"102","author":"Deps","year":"2008","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"31","key":"10.1016\/j.smim.2018.06.003_bib0605","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/j.vaccine.2008.04.083","article-title":"Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production","volume":"26","author":"Elias","year":"2008","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.smim.2018.06.003_bib0610","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.2736","article-title":"Effect of helminth-induced immunity on infections with microbial pathogens","volume":"14","author":"Salgame","year":"2013","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0615","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/0074-02760160395","article-title":"A tale of two neglected tropical infections: using GIS to assess the spatial and temporal overlap of schistosomiasis and leprosy in a region of Minas Gerais, Brazil","volume":"112","author":"Phillips","year":"2017","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0620","doi-asserted-by":"crossref","first-page":"63","DOI":"10.47276\/lr.85.1.63","article-title":"Leprosy and lymphatic filariasis comorbidity: the case for an integrated functional limitation grading system","volume":"85","author":"Rawson","year":"2014","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.smim.2018.06.003_bib0625","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ebiom.2017.08.026","article-title":"Opening a can of worms: leprosy reactions and complicit soil-transmitted helminths","volume":"23","author":"Hagge","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.smim.2018.06.003_bib0630","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-016-1593-0","article-title":"Soil-transmitted helminth infections and leprosy: a cross-sectional study of the association between two major neglected tropical diseases in Indonesia","volume":"16","author":"Oktaria","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.smim.2018.06.003_bib0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004594","article-title":"Genetic susceptibility and predictors of paradoxical reactions in buruli ulcer","volume":"10","author":"Barogui","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.smim.2018.06.003_bib0640","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2014.12.030","article-title":"Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis","volume":"32","author":"Bell","year":"2015","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.smim.2018.06.003_bib0645","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jis588","article-title":"Crohn\u2019s disease susceptibility genes are associated with leprosy in the Vietnamese population","volume":"206","author":"Grant","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.smim.2018.06.003_bib0650","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/fmb.11.39","article-title":"Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome","volume":"6","author":"Cardoso","year":"2011","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.smim.2018.06.003_bib0655","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdermsci.2016.01.001","article-title":"Integrative analyses of leprosy susceptibility genes indicate a common autoimmune profile","volume":"82","author":"Zhang","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.smim.2018.06.003_bib0660","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00060-17","article-title":"Longitudinal IP-10 serum levels are associated with the course of disease activity and remission in rheumatoid arthritis","author":"van Hooij","year":"2017","journal-title":"Clin. Vaccine Immunol. : CVI"},{"issue":"9","key":"10.1016\/j.smim.2018.06.003_bib0665","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/MIB.0000000000000477","article-title":"Immunoregulatory pathways involved in inflammatory bowel disease","volume":"21","author":"Fonseca-Camarillo","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"12","key":"10.1016\/j.smim.2018.06.003_bib0670","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1371\/journal.pntd.0000351","article-title":"development and validation of a severity scale for leprosy type 1 reactions","volume":"2","author":"Walker","year":"2008","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.smim.2018.06.003_bib0675","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.1103452","article-title":"New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy","volume":"188","author":"Geluk","year":"2012","journal-title":"J. Immunol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532318300642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532318300642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:39:51Z","timestamp":1693733991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532318300642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":135,"alternative-id":["S1044532318300642"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2018.06.003","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlates of immune exacerbations in leprosy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}